On November 12, the second RIKEN CLST – Karolinska Institutet – SciLifeLab Joint Symposium was held at Yokohama campus of RIKEN. This is the event between RIKEN CLST and Sweden’s two major institutes, Karolinska Institutet and Science for Life Laboratory (SciLifeLab). The first joint symposium was held last October in Stockholm with the objective to build a broader and closer partnership between RIKEN CLST, Karolinska Institutet, and SciLifelab. 

This year's topic, Structural Biology for Drug Discovery, is of great interest to the three parties, and is one of the main activities of RIKEN CLST. We also covered topics related to open innovation in drug discovery, an area of importance today for Japan and Sweden. The symposium was open to the public and attended by about 120 people. Dozens of people from universities or pharmaceutical companies took part in.

To see the program, please click here.